Non-invasive urine and vaginal fluid test offers hope for early womb cancer detection

While not yet a standalone diagnostic tool, it performs well enough to rule out

British doctors have developed a new non-invasive test using urine and vaginal fluid samples to detect womb cancer in women experiencing postmenopausal bleeding. The method aims to speed up diagnosis for thousands of women at lower risk, reducing the need for more invasive procedures. Early trials show promise in triaging suspected cases quickly and accurately. The test works by analysing molecular markers in bodily fluids that are associated with endometrial cancer. Researchers say it could be used in clinics to prioritise who needs further investigation, such as ultrasound or biopsy. This approach may reduce anxiety and waiting times for patients while ensuring those with symptoms are not missed. How accurate is the new fluid-based screening method? Initial studies indicate the test has high sensitivity in detecting womb cancer, particularly in women with abnormal bleeding after menopause.

Latest news

President Trump Declares Force the Path to Peace at UN AssemblyChina’s Clean Energy Exports Surge Amid Iran Conflict, Boosting Xi’s Leverage in U.S. TalksCarney Commits $100 Million to Palestinian Aid atFamily Claims Neglect Led to Death of Costa Rican Detainee in ICE Custody

While not yet a standalone diagnostic tool, it performs well enough to rule out cancer in many low-risk cases. Scientists stress that larger trials are needed before widespread clinical use. Could this change how doctors handle postmenopausal bleeding? Yes, the test could shift current guidelines by offering a simple first step for women reporting bleeding after menopause. Instead of immediately referring all patients for invasive exams, doctors might use this test to filter out those unlikely to have cancer. This would allow faster focus on high-risk cases while sparing others unnecessary procedures. Frequently Asked Questions Is the test painful or uncomfortable? No, it only requires collecting urine and a vaginal swab, both of which are quick and painless for the patient. When might this test be available in hospitals?

It is still in the research phase; approval and rollout could take several years depending on further trial results and regulatory review. Does a negative result mean cancer is definitely ruled out? Not entirely; a negative result suggests low likelihood, but doctors may still recommend follow-up if symptoms persist or risk factors remain.